Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [21] OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy
    Teussink, Michel M.
    Breukink, Myrte B.
    van Grinsven, Mark J. J. P.
    Hoyng, Carel B.
    Klevering, B. Jeroen
    Boon, Camiel J. F.
    de Jong, Eiko K.
    Theelen, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (09) : 5229 - 5237
  • [22] Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy
    Nazanin Ebrahimiadib
    Arash Mirzaei
    Shaghayegh Esfandiarifard
    Sonal Tuli
    Ehsan Najibzadeh
    Marjan Imani Fooladi
    Kaveh Fadakar
    Scientific Reports, 13
  • [23] Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy
    Ebrahimiadib, Nazanin
    Mirzaei, Arash
    Esfandiarifard, Shaghayegh
    Tuli, Sonal
    Najibzadeh, Ehsan
    Fooladi, Marjan Imani
    Fadakar, Kaveh
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Liu, Chun-Fu
    Chen, Lee-Jen
    Tsai, Shawn H.
    Lai, Chi-Chun
    Chan, Wei-Chun
    Wu, Wei-Chi
    Wang, Nan-Kai
    Chen, Kuan-Jen
    Hwang, Yih-Shiou
    Chen, Yen-Po
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (05) : 400 - 405
  • [25] Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Tsonaka, Roula
    Feenstra, Helena M. A.
    Dijkman, Greet
    Peters, Petrus J. H.
    Diederen, Roselie M. H.
    Hoyng, Carel B.
    Schlingemann, Reinier O.
    Boon, Camiel J. F.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 233 : 101 - 110
  • [26] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Andrea Servillo
    Riccardo Sacconi
    Ilaria Zucchiatti
    Elena Grachova
    Lea Querques
    Francesco Prascina
    Beatrice Tombolini
    Giorgio Dorin
    Martin Mainster
    Francesco Bandello
    Giuseppe Querques
    Ophthalmology and Therapy, 2023, 12 : 2199 - 2208
  • [27] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Servillo, Andrea
    Sacconi, Riccardo
    Zucchiatti, Ilaria
    Grachova, Elena
    Querques, Lea
    Prascina, Francesco
    Tombolini, Beatrice
    Dorin, Giorgio
    Mainster, Martin
    Bandello, Francesco
    Querques, Giuseppe
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 2199 - 2208
  • [28] Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Cheng, Zhihang
    Babiker, Salma
    Lenfestey, Pauline
    Beare, Nick
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [29] QUANTIFICATION OF METAMORPHOPSIA IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-DOSE VERTEPORFIN PHOTODYNAMIC THERAPY
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (05): : 964 - 970
  • [30] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    R Uetani
    Y Ito
    K Oiwa
    K Ishikawa
    H Terasaki
    Eye, 2012, 26 : 640 - 649